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osting by EAbstract Background: Identiﬁcation of patients with ischemic cardiomyopathy (ICM) from those
with idiopathic dilated cardiomyopathy (DCM) is important therapeutically and prognostically.
Objective: To assess the validity of the distance between the mitral leaﬂets coaptation point and the
mitral annular plane (CPMA) at low dose dobutamine stress echocardiography (DSE) for differen-
tiation between ICM and DCM.
Patients and methods: Echocardiographic indices and CPMA were measured at baseline and during
dobutamine infusion for 50 patients who were presenting with heart failure and reduced ejection
fraction (EF). Patients were divided into two groups depending on coronary angiographic ﬁndings,
group I (ICM with signiﬁcant coronary artery disease) and group II (DCM with normal coronary
arteries).
Results: Compared with baseline values, the CPMA at low dose DSE decreased signiﬁcantly in ICM
patients (11.8 ± 2.2 vs 8 ± 1.2 mm, P< 0.01) while it showed non-signiﬁcant change in patients
with DCM (11.66 ± 2.3 vs 11.99 ± 2.22 mm, P> 0.05). At low dose DSE ICM group showed a
high statistically signiﬁcant negative correlation between CPMA and both EF (r= 0.749,
P< 0.0001) and viability index (r= 0.782, P< 0.0001) and signiﬁcant positive correlation with
WMSI (r= 0.79, P< 0.0001). Receiver operating characteristic (ROC) CPMA cut-off
value 6 9 mm at low dose DSE, had sensitivity of 76.92%, speciﬁcity of 85.71% in detecting
patients with ICM.oo.com (K.M. Abd El-Salam).
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148 K.M. Abd El-Salam et al.Conclusion: Measurement of CPMA at low dose DSE might help in identifying patients with ICM
from those with DCM.
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Variables Group I
(n= 26)
Group II
(n= 24)
P
Age (years) 56 ± 8 54 ± 7 >0.05
Sex (No. & %)
M 19 (73.07%) 16 (66.67%) >0.05
F 7 (26.92%) 8 (33.33%) >0.05
Smoking (No. & %) 17 (65.38%) 14 (58.33%) >0.05
Hypertension (No. & %) 17 (65.38%) 12 (50%) <0.05
D.M. (No. & %) 10 (38.46%) 7 (29.17%) <0.05
Dyslipidemia (No. & %) 22 (84.61) 10 (41.67%) <0.05
M=Male, F = Female, D.M. = Diabetes mellitus.
P< 0.05 = Signiﬁcant, P> 0.05 = Non-signiﬁcant.1. Introduction
ICM is chronic LV dysfunction due to the sequel of diffuse
coronary artery disease giving a picture which is often indistin-
guishable from DCM.1
Under normal conditions, the coaptation point of the
mitral valve leaﬂets in systole practically reaches the level of
the mitral annulus. This point is displaced apically in abnormal
conditions, such as morphological abnormalities of the leaﬂets
or dilatation of the left ventricle.2
As a result of the chronic hypoperfusion state, the LV
becomes larger and more spherically draws the papillary mus-
cles out from the mitral valve annulus and results in abnormal
cooptation of the mitral valve.3,4
The aim of this study was to assess the validity of (CPMA)
at low dose DSE for differentiation between ICM and DCM in
patients with LV systolic dysfunction.
Patients and methods
A total number of 50 patients presenting with heart failure and
reduced EF <50% were referred for coronary angiography.
According to angiographic ﬁndings patients were classiﬁed
into two groups, group I included 26 patients with signiﬁcant
coronary artery disease (ICM group) and group II included
24 patients with normal coronary arteries (DCM group). All
patients gave their informed consent. The study was approved
by the ethics committee of our institute.
Dobutamine protocol
Dobutamine was administered intravenously from 5 to 40 lg/
kg/min in 3-min dose increments during continuous electrocar-
diogram and blood pressure monitoring. Atropine (to a total
dose of 1 mg) was added if 85% of the maximum age-predicted
heart rate was not achieved by the end of the dobutamine pro-
tocol. The test was concluded at the peak dose or earlier if the
patient developed ischemia or had intolerable side effects.5
Stress echocardiography
Before stress testing, baseline echocardiographic study was
done with an ultrasound equipment (HP Sonos 5500, USA)
with the patient in the supine and left lateral position. Stan-
dard 2-dimensional views were obtained from parasternal
(long and short axis) and apical (4- and 2-chambers views)
windows. Digital acquisition of images was obtained at rest,
at low dobutamine dose (10 mg/kg/min), at peak stress, and
during recovery for side-by-side display in quad-screen
format.5
All segments were scored at rest and stress as normal or
abnormal (hypokinetic, akinetic, or dyskinetic), with the 16-
segment model and the interpretation criteria of the American
Society of Echocardiography.5 The WMSI was calculated asthe sum of WMS of each segment divided by total umber of
segments and the viability index was deﬁned as the number
of dyssynergic segments showing improvement at LDD di-
vided by the total number of dyssynergic segments.6
CPMA was measured as the distance between mitral leaﬂets
coaptation point and the mitral annular plane at the end sys-
tole.2 The EF was measured by the modiﬁed Simpson
method.7
Statistical analysis
Continuous variables are expressed as mean ± standard devi-
ation. The unpaired Student t test was used to compare contin-
uous variables, and categorical data were compared using the
Chi-square (v2) test correlation between variables which was
done using correlation coefﬁcient (r) to detect if changes in
one variable were accompanied by changes in other variable.
Agreement test (kappa coefﬁcient) was used to relate low dose
CPMA with the type of dobutamine response. Cut-off values
for CPMA were estimated by receiver operating characteristic
curve (R.O.C.). Statistical signiﬁcance was set at less than 0.05
level.8
Results
Table 1 shows the demographic data of the study population.
Hypertension, DM and hyperlipidemia were signiﬁcantly more
common in ICM group compared with the DCM group {17
(65.38%) vs 12 (50%), P< 0.05}, {10 (38.46%) vs 7
(29.17%), P < 0.05} and {22 (84.61) vs 10 (41.67%), P
< 0.05}, respectively.
Compared with baseline values, patients with ICM showed
signiﬁcant decrease of both CPMA and WMSI, whereas the
EF was signiﬁcantly increased at low dose DSE {11.8 ± 2.2
vs 8 ± 1.2 mm, P< 0.01}, {1.3 ± 0.1 vs 1.06 ± 0.07 mm,
P< 0.05} and {41.8 ± 4.2 vs 44.3 ± 5.3 mm, P< 0.05},
respectively (Table 2, Fig. 1).
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Figure 1 CPMA at baseline and at low dose DSE in the ICM
and DCM groups.
Table 2 CPMA, EF and WMSI at baseline and low dose DSE in the study groups.
Group I (n= 26) Group II (n= 24)
Baseline Low dose DSE P Baseline Low dose DSE P
CPMA (mm) 11.8 ± 2.2 8 ± 1.2 <0.01 11.66 ± 2.3 11.99 ± 2.22 >0.05
EF (%) 41.8 ± 4.2 44.3 ± 5.3 <0.05 35 ± 4.8 38.3 ± 2.8 >0.05
WMSI 1.3 ± 0.1 1.06 ± 0.07 <0.05 1.6 ± 0.1 1.79 ± 0.04 >0.05
EF = Ejection fraction, WMSI =Wall motion score index.
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ICM patients showed a signiﬁcantly higher EF {44.3 ± 5.3%
vs 38.3 ± 2.8%, P < 0.01}, smaller CPMA {8 ± 1.2 vs
11.99 ± 2.22 mm, P < 0.01}, lower WMSI {1.06 ± 0.07 vs
1.79 ± 0.04, P < 0.01} and a higher viability index
{0.8 ± 0.17 vs 0.1 ± 0.16, P< 0.01} Table 3.
At low dose DSE ICM group showed a high statistically
signiﬁcant negative correlation between CPMA and both EF
(r= 0.749, P< 0.0001) and viability index (r= 0.782,
P< 0.0001) and signiﬁcant positive correlation with WMSI
(r= 0.79, P< 0.0001) Figs. 2 and 3.
ROC analysis showed a cut-off value of CPMA 6 9 mm at
low dose DSE could identify patients with ICM and differen-
tiate them from those with DCM with a sensitivity of 76.92%
and a speciﬁcity of 85.71%. The biphasic response was able to
detect ICM patients with a sensitivity of 69.23% and a speci-
ﬁcity of 100%.Table 3 Echocardiographic ﬁndings at low dose dobutamine in the
Variables Group I (n= 26)
EF (%) 44.3 ± 5.3
CPMA (mm) 8 ± 1.2
WMSI 1.06 ± 0.07
Viability index (VI) 0.8 ± 0.17
CPMA= The distance between the mitral leaﬂets coaptation point and
motion score index.This cut-off value (CPMA 6 9 mm) at low dose showed
agreement with biphasic response (kappa coefﬁcient = 1,
P< 0.001) while it showed disagreement with other types of
dobutamine response (P> 0.05) Table 4.
Discussion
Identiﬁcation of patients with ICM is of utmost importance so
as to improve their outcome by directing patients for attempts
at coronary revascularization to salvage the chronically hyp-
operfused myocardium.
This study aimed to assess the validity of CPMA at low
dose DSE in identiﬁcation of patients with ICM from those
presenting with heart failure and reduced LV systolic function.
The occurrence of incomplete mitral leaﬂet closure was ini-
tially thought to be caused by dyskinesia of the left ventricular
myocardium beneath one of the papillary muscles. Godley and
colleagues9 speciﬁcally detected incomplete mitral leaﬂet clo-
sure in the vast majority of patients with mitral valve regurgi-
tation after myocardial infarction.3
In subsequent studies, it was shown that incomplete mitral
leaﬂet closure is associated with raised left ventricular ﬁlling
pressure and is not speciﬁc for the subset of patients with pap-
illary muscle dysfunction or acute myocardial infarction.10
In this study at low dose DSE, patients with ICM showed a
reduction in CPMA and WMSI with increase in EF, while in
DCM patients all these indices showed non-signiﬁcant
changes. These ﬁndings may be explained by the recruitment
of contractile reserve during low dose DSE which lead to the
improvement of systolic function.
Kaul and colleagues11 conclusively showed that incomplete
mitral leaﬂet closure was related to reduced left ventricular
function and CPMA correlated with left ventricular and mitral
annulus size, but fractional shortening of the left ventricle was
the only predictor of the presence of incomplete mitral leaﬂet
closure on multivariate analysis.
It was suggested that a restriction in the motion of the leaf-
lets due to CAD leading to leaﬂets tethering which displaces
the coaptation zone from the mitral annulus toward the apexstudy groups.
Group II (n= 24) P
38.3 ± 2.8 <0.01
11.99 ± 2.22 <0.01
1.79 ± 0.04 <0.01
0.1 ± 0.16 <0.01
the mitral annular plane, EF = Ejection fraction, WMSI =Wall
Figure 2 Correlation between low dose CPMA and viability
index in ICM group.
Figure 3 Correlation between low dose CPMA and EF in ICM
group.
Table 4 Association between CPMA 6 9 mm at low dose and
dobutamine response (agreement test).
Response Low dose
CPMA
6 9 mm
Low dose
CPMA
> 9 mm
Kappa
coeﬃcient
P
Biphasic (n) 17 1 1 <0.01
Sustained improvement (n) 5 0 0.39 >0.05
No change (n) 0 16 0.13 >0.05
Worsening (n) 0 11 0.09 >0.05
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valve in systole.12,13
Kinney and Frangi10 studied 73 patients with incomplete
mitral leaﬂet closure and found that only 10% of them had
acute myocardial infarction. The most important determining
factor for the occurrence of incomplete mitral leaﬂet closure
was the presence of mitral valve ‘‘B bumps’’ on M mode,
which is typically associated with raised left ventricular end
diastolic pressure and an increase in left ventricular end dia-
stolic dimension in both dilated and ischemic cardiomyopathy.
Other investigators also suggested that local remodeling of
the left ventricle displaces papillary muscles and leads to a trac-
tion on the mitral leaﬂets. Incomplete leaﬂet closure may also
be the consequence of regional wall motion abnormalities ob-
served after a myocardial infarction or in severe chronic myo-
cardial ischemia.14
CPMA is also favored by the imbalance between tethering
forces and decreased ventricular forces acting to close the leaf-
lets. These decreased ventricular forces are the consequence of
the left ventricular contractile dysfunction.15
In this study, patients with ICM showed a statistically sig-
niﬁcant negative correlation between CPMA and EF, viability
index and signiﬁcant positive correlation with WMSI, more-
over, there was a highly signiﬁcant agreement between
CPMA< 9 mm at low dose DSE and biphasic response at
DSE.
After administration of an inotrop (dobutamine), contrac-
tile function improved and the distance between the mitral
annulus plane and the coaptation point of the mitral leaﬂets
(that is, the CPMA) decreased, further supporting our hypoth-
esis that this is an index of systolic function.
Conclusion
From this study, it could be concluded that the use of CPMA
during low DSE as a marker of myocardial viability can be of
help in conjunction with other parameters used in this regard
such as the biphasic or sustained improvement types of dobu-
tamine responses, in the identiﬁcation of patients with ICM.
Clinical implication
CPMA at low dose DSE may be of help in diagnosing patients
with ICM who might have viable myocardium and who can
beneﬁt from revascularization and could be used in patients
with suboptimal echo window in contrast to other indices used
during DSE that depend on the analysis of wall motion of the
LV and hence an optimal echo window is a must to get good
results.
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